Collaborative

 

Analyst coverage

Institute
Analyst
Target price
Report
Intron Health Research
Dominic Rose
47 CHF
view
Baader Bank
Amandeep Goyal
69.8 CHF
view
Stifel
Daniel Jelovcan
68 CHF
view

News

Press Releases

23.1.23
Stifel initiates research coverage of Xlife Sciences
20.1.23
Xlife Sciences: Swiss portfolio company Axenoll receives strategically significant patent by the European Patent Office
16.1.23
Xlife Sciences portfolio company launches project to research a potential therapy for amyotrophic lateral sclerosis (ALS)
Archive

Ad hoc News

26.5.2023
Xlife Sciences publishes agenda for Annual General Meeting 2023
27.4.2023
Xlife Sciences: Valuation Report 2022 confirms and emphasizes long-term portfolio potential
20.4.2023
Xlife Sciences publishes 2022 results and 2023 outlook
Archive

Downloads

Financial Reports

April 27, 2023
Valuation Report 2022
April 20, 2023
Annual Report 2022
September 28, 2022
Half-Year Report 2022
May 9, 2022
Valuation Report 2021
April 29, 2022
Annual Report 2021
February 8, 2022
Interim financial statement Q3 2021 (only in german)
August 5, 2021
Semi-Annual Report 2021
Half-year results (only available in German)
May 29, 2020
Annual statement 2020

Sign up for our media releases